Communiqués Eli Lilly and Company Lima

Actions

US5324571083

Cours en clôture Lima Autres places de cotation 00:00:00 27/06/2024			Varia. 5j.	Varia. 1 janv.
903,6 ^USD	0,00 %		+4,82 %	0,00 %

28/06	Atossa Therapeutics double la dose de Z-Endoxifen dans son étude de phase 2 sur le cancer du sein	MT
28/06	L'EMA déclare que le CHMP a donné un avis positif sur le vaccin mResvia RSV mRNA pour la prévention chez les adultes de 60 ans et plus	RE

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases	27/06	AQ
Augustine Therapeutics announces EUR17 million Series A1 financing round	27/06	AQ
Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteria	25/06	PR
Lilly Declares Third-Quarter 2024 Dividend	24/06	PR
WHO and Eli Lilly caution patients against falling for fake versions of popular weight-loss drugs	20/06	AQ
Eli Lilly and : Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products	20/06	PU
Eli Lilly and : An Open Letter From Eli Lilly and Company Regarding Certain Practices Related to Mounjaro® and Zepbound®	20/06	PU
Lilly's tirzepatide was superior to placebo for MASH resolution, and more than half of patients achieved improvement in fibrosis at 52 weeks	08/06	PR
Lilly announces departure of Anat Ashkenazi, chief financial officer	05/06	PR
Eli Lilly and Company - Melissa Seymour to join Lilly as executive vice president of Global Quality	05/06	AQ
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	04/06	AQ
Eli Lilly and : Asco Lilly Oncology Presentation	03/06	PU
AKTIS ONCOLOGY NAMES TYLER BENEDUM, Ph.D., CHIEF TECHNICAL OFFICER	31/05	AQ
Lilly, UNICEF expand support to help millions of young people at risk of noncommunicable diseases	29/05	PR
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	29/05	AQ
Lilly to Participate in Goldman Sachs 45th Annual Global Healthcare Conference	28/05	PR
Major manufacturing investment to support API production for tirzepatide	27/05	AQ
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro	24/05	AQ
Eli Lilly and : 2015 Global Health Programs Report	24/05	PU
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines	24/05	PR

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

A la une

David Ricks, PDG d'Eli Lilly : Un marche de plus d'un milliard de personnes

Le 12 mars 2024 à 19:47